Librodyn

Fluid extract from ivy leaves (Hedera helix) and thyme (Thymus spp.), the active ingredient in Librodyn, is a herbal oral extract presented as a liquid oral preparation for oral use. It is traditionally employed to support respiratory comfort in individuals with cough or bronchial irritation.

GNH USA supplies Librodyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Librodyn, containing ivy leaf and thyme extracts, is used as an herbal respiratory support for cough and bronchial irritation. - Acute cough: helps loosen mucus and ease coughing. - Bronchitis: supports airway clearance and reduces irritation. - Upper respiratory tract infection: may provide symptomatic relief of sore throat and cough.

Librodyn may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Taste disturbance: unusual after‑taste in the mouth. - Mild skin irritation: localized redness or itching.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling. - Bronchospasm: sudden tightening of airway muscles. - Liver enzyme elevation: abnormal liver function tests. - Angioedema: swelling of face, lips, or tongue.

Before using Librodyn, consider the following precautions. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Children: only under pediatric supervision. - Known allergy to ivy or thyme: avoid product. - Anticoagulant therapy: monitor for increased bleeding risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Librodyn may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Concomitant use with potent bronchodilators may cause excessive airway stimulation. - Use with known hypersensitivity agents may increase risk of allergic reaction.

Moderate Interactions (Monitor Closely): - Anticoagulant therapy: potential for increased bleeding. - Other herbal cough preparations: may augment sedative or antitussive effects. - CYP450 substrates: theoretical alteration of metabolism; observe clinical response.